Cargando…
New insights on IL‑36 in intestinal inflammation and colorectal cancer (Review)
Interleukin (IL)-36 is a member of the IL-1 superfamily, which includes three receptor agonists and one antagonist and exhibits a familial feature of inflammatory regulation. Distributed among various tissues, such as the skin, lung, gut and joints, the mechanism of IL-36 has been most completely in...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189745/ https://www.ncbi.nlm.nih.gov/pubmed/37206554 http://dx.doi.org/10.3892/etm.2023.11974 |
_version_ | 1785043149907820544 |
---|---|
author | Li, Minghui Jiang, Wei Wang, Zehui Lu, Yihan Zhang, Jun |
author_facet | Li, Minghui Jiang, Wei Wang, Zehui Lu, Yihan Zhang, Jun |
author_sort | Li, Minghui |
collection | PubMed |
description | Interleukin (IL)-36 is a member of the IL-1 superfamily, which includes three receptor agonists and one antagonist and exhibits a familial feature of inflammatory regulation. Distributed among various tissues, such as the skin, lung, gut and joints, the mechanism of IL-36 has been most completely investigated in the skin and has been used in clinical treatment of generalized pustular psoriasis. Meanwhile, the role of IL-36 in the intestine has also been under scrutiny and has been shown to be involved in the regulation of various intestinal diseases. Inflammatory bowel disease and colorectal cancer are the most predominant inflammatory and neoplastic diseases of the intestine, and multiple studies have identified a complex role for IL-36 in both of them. Indeed, inhibiting IL-36 signaling is currently regarded as a promising therapeutic approach. Therefore, the present review briefly describes the composition and expression of IL-36 and focuses on the role of IL-36 in intestinal inflammation and colorectal cancer. The targeted therapies that are currently being developed for the IL-36 receptor are also discussed. |
format | Online Article Text |
id | pubmed-10189745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-101897452023-05-18 New insights on IL‑36 in intestinal inflammation and colorectal cancer (Review) Li, Minghui Jiang, Wei Wang, Zehui Lu, Yihan Zhang, Jun Exp Ther Med Review Interleukin (IL)-36 is a member of the IL-1 superfamily, which includes three receptor agonists and one antagonist and exhibits a familial feature of inflammatory regulation. Distributed among various tissues, such as the skin, lung, gut and joints, the mechanism of IL-36 has been most completely investigated in the skin and has been used in clinical treatment of generalized pustular psoriasis. Meanwhile, the role of IL-36 in the intestine has also been under scrutiny and has been shown to be involved in the regulation of various intestinal diseases. Inflammatory bowel disease and colorectal cancer are the most predominant inflammatory and neoplastic diseases of the intestine, and multiple studies have identified a complex role for IL-36 in both of them. Indeed, inhibiting IL-36 signaling is currently regarded as a promising therapeutic approach. Therefore, the present review briefly describes the composition and expression of IL-36 and focuses on the role of IL-36 in intestinal inflammation and colorectal cancer. The targeted therapies that are currently being developed for the IL-36 receptor are also discussed. D.A. Spandidos 2023-04-21 /pmc/articles/PMC10189745/ /pubmed/37206554 http://dx.doi.org/10.3892/etm.2023.11974 Text en Copyright: © Li et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Review Li, Minghui Jiang, Wei Wang, Zehui Lu, Yihan Zhang, Jun New insights on IL‑36 in intestinal inflammation and colorectal cancer (Review) |
title | New insights on IL‑36 in intestinal inflammation and colorectal cancer (Review) |
title_full | New insights on IL‑36 in intestinal inflammation and colorectal cancer (Review) |
title_fullStr | New insights on IL‑36 in intestinal inflammation and colorectal cancer (Review) |
title_full_unstemmed | New insights on IL‑36 in intestinal inflammation and colorectal cancer (Review) |
title_short | New insights on IL‑36 in intestinal inflammation and colorectal cancer (Review) |
title_sort | new insights on il‑36 in intestinal inflammation and colorectal cancer (review) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189745/ https://www.ncbi.nlm.nih.gov/pubmed/37206554 http://dx.doi.org/10.3892/etm.2023.11974 |
work_keys_str_mv | AT liminghui newinsightsonil36inintestinalinflammationandcolorectalcancerreview AT jiangwei newinsightsonil36inintestinalinflammationandcolorectalcancerreview AT wangzehui newinsightsonil36inintestinalinflammationandcolorectalcancerreview AT luyihan newinsightsonil36inintestinalinflammationandcolorectalcancerreview AT zhangjun newinsightsonil36inintestinalinflammationandcolorectalcancerreview |